Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HIV and drug allergy.

M Pirmohamed1, B K Park

  • 1Department of Pharmacology and Therapeutics, The University of Liverpool, Liverpool, UK. munirp@liv.ac.uk

Current Opinion in Allergy and Clinical Immunology
|April 20, 2002
PubMed
Summary

HIV patients experience drug rashes 100x more often than the general population due to complex immune factors. Research is needed to understand hypersensitivity to new antiretroviral therapies and improve drug safety.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ultra-low-dose computed tomography (CT) protocol for guiding cryoablation in treating a T1a renal cell carcinoma (RCC): radiation doses and treatment outcomes.

Clinical radiology·2025
Same author

Organ preservation after neoadjuvant long-course chemoradiotherapy versus short-course radiotherapy.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Theileria buffeli infections in grazing cattle in the Republic of Korea.

Tropical biomedicine·2021
Same author

Proteomic profiling of rectal cancer reveals acid ceramidase is implicated in radiation response.

Journal of proteomics·2018
Same author

Implications of HLA-allele associations for the study of type IV drug hypersensitivity reactions.

Expert opinion on drug metabolism & toxicology·2018
Same author

Exome sequencing of synchronously resected primary colorectal tumours and colorectal liver metastases to inform oncosurgical management.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2017

Area of Science:

  • Immunology
  • Pharmacology
  • Infectious Diseases

Background:

  • Drug-related rashes are significantly more prevalent in HIV-positive individuals compared to the general population.
  • Potential contributing factors include altered drug metabolism, oxidative stress, cytokine dysregulation, and immune hyperactivation in HIV patients.
  • HIV infection itself may promote immune responses over tolerance, exacerbating drug hypersensitivity.

Purpose of the Study:

  • To investigate the reasons behind the increased incidence of drug-related rashes in HIV-positive patients.
  • To examine the evolving landscape of drugs implicated in hypersensitivity reactions following the introduction of highly active antiretroviral therapy (HAART).
  • To highlight the need for research into the immune-mediated mechanisms of hypersensitivity to newer antiretroviral drugs.

Main Methods:

  • Review of existing literature on drug hypersensitivity in HIV patients.
  • Comparison of implicated drugs before and after the advent of HAART.
  • Analysis of available laboratory evidence for hypersensitivity mechanisms, particularly for co-trimoxazole and newer antiretrovirals.

Main Results:

  • Drug-related rashes are estimated to be 100 times more common in HIV-positive patients.
  • The spectrum of drugs causing hypersensitivity has shifted with HAART, with decreased use of co-trimoxazole and increased use of abacavir, NNRTIs (e.g., nevirapine), and PIs (e.g., amprenavir).
  • Laboratory evidence supports immune system involvement in co-trimoxazole hypersensitivity, but such evidence is lacking for newer antiretrovirals, where hypersensitivity is presumed immune-mediated based on symptoms.

Conclusions:

  • The high incidence of drug rashes in HIV patients is likely multifactorial, involving complex immune system interactions.
  • Understanding the immune-mediated mechanisms of hypersensitivity to newer antiretrovirals is crucial for improving their benefit-risk profile.
  • Further research is essential for future drug development and optimizing treatment strategies in HIV management.

Related Experiment Videos